by admin | Sep 15, 2011 | My blogs
Brief clinical trial results from the recent ESC meeting in Paris: ARISTOTLE: Apixaban (factor Xa inhibitor) bests warfarin in preventing stroke in patients with non-valvular atrial fibrillation. PRODIGY: Increased bleeding complications in patients taking 24 vs. 6...
Recent Comments